Cargando…
Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications
BACKGROUND: Inclusion bodies (IBs) are biologically active protein aggregates forming natural nanoparticles with a high stability and a slow-release behavior. Because of their nature, IBs have been explored to be used as biocatalysts, in tissue engineering, and also for human and animal therapies. T...
Autores principales: | Roca-Pinilla, Ramon, Fortuna, Sara, Natalello, Antonino, Sánchez-Chardi, Alejandro, Ami, Diletta, Arís, Anna, Garcia-Fruitós, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650227/ https://www.ncbi.nlm.nih.gov/pubmed/32887587 http://dx.doi.org/10.1186/s12934-020-01425-x |
Ejemplares similares
-
Controlled Localization of Functionally Active Proteins to Inclusion Bodies Using Leucine Zippers
por: Choi, Su-Lim, et al.
Publicado: (2014) -
A Heterospecific Leucine Zipper Tetramer
por: Deng, Yiqun, et al.
Publicado: (2008) -
Lactiplantibacillus plantarum: a new example of inclusion body producing bacteria
por: Baltà-Foix, Ricardo, et al.
Publicado: (2023) -
The future of recombinant host defense peptides
por: Roca-Pinilla, Ramon, et al.
Publicado: (2022) -
Glucocorticoid Induced Leucine Zipper in Lipopolysaccharide Induced Neuroinflammation
por: Witek, Emily, et al.
Publicado: (2019)